Triofan Antitussif Levodrop 6 mg/ml, sirop

7680704180012 CH-70418 Sirup

No image available

Article details

Package size
150
Selling units
150
Measure
ml
Galenic form
Sirup
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/08/2026
Patient information leaflet
Français
28/08/2026
Patient information leaflet
Italien
28/08/2026
Summary of Product Characteristics
Allemand
28/08/2026
Summary of Product Characteristics
Français
28/08/2026
Summary of Product Characteristics
Italien
28/08/2026

Detailed composition

Substance Quantity Type Category
levodropropizinum
6.0 MG Substance Wirkstoff (Principe actif)
E 218
1.0 MG Substance HBESI
propylis parahydroxybenzoas
0.2 MG Substance HBESI
saccharum
400.0 MG Substance HBESI
acidum citricum monohydricum
- Substance HNIDK
aromatica
- Substance AROMA
ethanolum
1.39 MG Substance HBESI
aqua purificata
- Substance HNIDK

Authorization holder

Verfora SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
70418
Drug name
Triofan Antitussif Levodrop, sirop
Galenic form
SIRU
ATC Code
R05DB27
Authorization status
Z
Dispensing category
D
First authorization
12/08/2026
Authorization expiration date
11/08/2031
IT Number
03.01.2.
Domain
Human medicine

Package details

Description (FR)
TRIOFAN Antitussif Levodrop 6 mg/ml siroup 6 mg 15
Description (DE)
TRIOFAN Antitussif Levodrop 6 mg/ml Sirup 6 mg 150
Market launch
07/09/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data